ADAP - Adaptimmune Therapeutics plc (ADAP) CEO James Noble on Q2 2019 Results - Earnings Call Transcript
Adaptimmune Therapeutics plc (ADAP)
Q2 2019 Results Conference Call
August 01, 2019 08:00 AM ET
Company Participants
Juli Miller - IR
James Noble - CEO
Adrian Rawcliffe - Incoming CEO
Rafael Amado - President, R&D
Conference Call Participants
Waleed Abdel-Naby - SunTrust Robinson Humphrey
Kelsey Goodwin - Guggenheim Securities
Marc Frahm - Cowen
Keith Tapper - Citi
Jonathan Chang - SVB Leerink
Jim Birchenough - Wells Fargo
Tony Butler - Roth Capital Partners
Presentation
Operator
Good morning, and welcome to the Second Quarter of 2019 Adaptimmune Earnings Conference Call. My name is Carla, and I